...
首页> 外文期刊>Biotechnology Journal: Healthcare,Nutrition,Technology >Fabrication of core-sheath structured fibers for model drug release and tissue engineering by emulsion electrospinning
【24h】

Fabrication of core-sheath structured fibers for model drug release and tissue engineering by emulsion electrospinning

机译:通过乳液静电纺丝制备用于模型药物释放和组织工程的芯鞘结构纤维

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A nanofibrous core-sheath structured scaffold incorporated with bioactive agents is supposed to promote cell migration, proliferation, and gene expressions through the controllable and sustainable release of bioactive agents from the fibers and the preservation of bioactivity. Here we present a novel and effective emulsion electrospinning method for obtaining fluorescein isothio-cyanate-dextran (FITC-dextran)/poly(lactic-co-glycolic acid) (PLCA) and type I collagen/PLGA fibrous composite scaffolds. Core-sheath structured fibers with average diameters of 665 nm for FITC-dextran/PLCA and 567 nm for collagen/PLGA were successfully fabricated. In vitro-release profile shows sustained release of encapsulated FITC-dextran from FITC-dextran/PLCA fibers for as long as 7 weeks. The osteoblastic activity of the collagen/PLCA nanofibrous scaffold was investigated employing the osteoblastic-like MC3T3-E1 cell line. The results of the lactate dehydrogenase assay suggested excellent cytocompatibility. Cell proliferation and alkaline phosphatase activity were also ameliorated on this emulsion-electrospun collagen/PLCA fibrous scaffold. All the results indicated that this composite scaffold could support the early stages of osteoblast behavior as well as the immediate/late stages. The emulsion electrospinning process has potential for application in drug-release devices and as a 3-D scaffold in bone regeneration.
机译:掺入生物活性剂的纳米纤维芯鞘结构支架被认为可以通过从纤维中控制和可持续释放生物活性剂并保持生物活性来促进细胞迁移,增殖和基因表达。在这里,我们提出了一种新颖而有效的乳液静电纺丝方法,用于获得异硫氰酸荧光素(FITC-葡聚糖)/聚乳酸-乙醇酸共聚物(PLCA)和I型胶原蛋白/ PLGA纤维复合支架。成功制造了芯鞘结构纤维,FITC-葡聚糖/ PLCA的平均直径为665 nm,胶原蛋白/ PLGA的平均直径为567 nm。体外释放曲线显示,封装的FITC-葡聚糖从FITC-葡聚糖/ PLCA纤维中持续释放长达7周。使用成骨细胞样MC3T3-E1细胞系研究了胶原蛋白/ PLCA纳米纤维支架的成骨活性。乳酸脱氢酶测定的结果表明具有优异的细胞相容性。在该乳液静电纺丝的胶原蛋白/ PLCA纤维支架上,细胞增殖和碱性磷酸酶活性也得到了改善。所有结果表明该复合支架可以支持成骨细胞行为的早期以及晚期/晚期。乳液静电纺丝工艺具有用于药物释放装置和在骨骼再生中用作3-D支架的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号